NGNE insider buying – Neurogene Inc.
3 insider purchases since 2016 worth $2.7M by 3 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2024-11-27.
Small company Public float $146M (latest 10-K, SEC). Share prices of small companies usually swing much more than those of large ones, in both directions, and are easier to move with little trading.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| AKKARAJU SRINIVAS 10% Owner | $1.3M 1× · 48,770 sh | 2024-11-26 2024-11-26 | – | 1,689,105 shares as of 2024-11-27 | Holds - never sold |
| McMinn Rachel CEO | $969,000 1× · 47,500 sh | 2024-11-22 2024-11-22 | 1× · $73,979 last 2026-03-26 | 1,344,307 shares as of 2026-03-30 | Sold part |
| Cvijic Christine Mikail CEO | $491,520 1× · 24,000 sh | 2024-11-22 2024-11-22 | 7× · $976,257 last 2026-07-06 | 84,040 shares as of 2026-07-07 | Sold part |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 8 | $1.1M |
| 2025 | 0 | – | – | 2 | $179,222 |
| 2024 | 3 | $2.7M | 3 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2024-11-27 | AKKARAJU SRINIVAS | 10% Owner | 48,770 | $25.83 | $1.3M | +2.9% | SEC |
| 2024-11-25 | McMinn Rachel | CEO | 47,500 | $20.40 | $969,000 | +3.8% | SEC |
| 2024-11-25 | Cvijic Christine Mikail | CEO | 24,000 | $20.48 | $491,520 | +45.4% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | Cvijic Christine Mikail | CEO | 4,800 | $36.12 | $173,358 | Pre-planned (10b5-1) | SEC |
| 2026-07-02 | Cvijic Christine Mikail | CEO | 4,800 | $34.71 | $166,594 | Pre-planned (10b5-1) | SEC |
| 2026-05-08 | Cvijic Christine Mikail | CEO | 9,600 | $31.25 | $300,048 | Pre-planned (10b5-1) | SEC |
| 2026-03-30 | McMinn Rachel | CEO | 3,352 | $22.07 | $73,979 | Pre-planned (10b5-1) | SEC |
| 2026-03-30 | Cvijic Christine Mikail | CEO | 2,558 | $21.62 | $55,304 | Pre-planned (10b5-1) | SEC |
| 2026-03-17 | Cvijic Christine Mikail | CEO | 4,045 | $20.81 | $84,178 | Pre-planned (10b5-1) | SEC |
| 2026-03-17 | Cobb Stuart | Officer | 6,797 | $20.81 | $141,446 | Pre-planned (10b5-1) | SEC |
| 2026-03-03 | Cvijic Christine Mikail | CEO | 4,800 | $25.11 | $120,528 | Pre-planned (10b5-1) | SEC |
| 2025-05-15 | Cobb Stuart | Officer | 6,797 | $15.15 | $102,975 | Pre-planned (10b5-1) | SEC |
| 2025-03-17 | Cvijic Christine Mikail | CEO | 4,501 | $16.94 | $76,247 | Pre-planned (10b5-1) | SEC |
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free